CFPCLearn

In episode 621, Tina, James and Mike K talk about the evidence around whole-body MRIs. We discuss how many abnormalities are found, how many cancers are actually found, and finally the lost opportunity costs. You need to know these numbers to talk to your patients about the value or lack thereof of doing this test. To claim your CPD credits, click the link below and then select "Claim Credits Now". https://cfpclearn.ca/podcast/bs-medicine-episode-621-whole-body-mri-for-cancer-screening-many-findings-little-benefit/

In episode 619, Mike K and James chat yet again with Émélie Braschi. The topic this time is the use of point-of-care ultrasound (POCUS) to help diagnose patients coming into emerg with dyspnea. The results certainly suggest this may be a useful tool. Tune in and find out if it is useful enough for you. To claim your CPD credits, click the link below and then select "Claim Credits Now". BS Medicine Episode #619: Scan, See, Decide: POCUS in the Evaluation of Dyspnea - CFPCLearn

In this episode of In the Clinic, the team discusses Nadia Hench, a 49-year-old woman following up regarding achiness, fatigue, and poor sleep. To claim your CPD credits, click the link below and then select "Claim Credits Now." In the Clinic Episode 57: Fibromyalgia - CFPCLearn

In episode 618, Mike K and James chat with Émélie Braschi who helps us go over, yet again, the evidence for the use of gabapentinoids. This time it is for the treatment of osteoarthritis. We then put the best available evidence into the context of the other treatments we have for osteoarthritis. Have a listen and find out if and/or where it might fit in. To claim your CPD credits, click the link below and then select "Claim Credits Now." BS Medicine Episode #618: From Nerve Pain to Knee Pain: Gabapentinoids for osteoarthritis - CFPCLearn

In episode 616, Tina and James discuss the issue around the evidence for using topical anesthetics to reduce the pain associated with IUD insertion. To help with this discussion, we bring in Jessica Kirkwood and Caitlin Finley to provide practical information and insight. The evidence is really interesting and worth knowing. So have a listen – it might change your practice. To claim your CPD credits, click the link below and then select "Claim Credits Now." BS Medicine Episode #616: Taking the "ouch" out of IUD insertion: Can topical lidocaine help? - CFPCLearn

In this episode of In the Clinic, the team discusses Adrian Cage, a 42-year-old father of two presenting with anxiety. To claim your CPD credits, click the link below and then select "Claim Credits Now." In the Clinic Episode 54: Anxiety - CFPCLearn

In episode 615, Mike and James revisit the evidence around using electronic cigarettes for smoking cessation. We look at smoking cessation rates between the use of e-cigarettes, nicotine-free e-cigarettes, nicotine replacement therapy or varenicline. Tune in to hear about the numbers from the trials – it may inform you as to what you could recommend to smokers in your practice. To claim your CPD credits, click the link below and then select "Claim Credits Now." BS Medicine Episode #615: Vape Expectations: Are electronic cigarettes the real deal for smoking cessation? - CFPCLearn

In episode 613, Mike and James discuss with Jessica Kirkwood the evidence for post-exposure prophylaxis of sexually transmitted infections. We go over the 4 RCTs that have looked at the value of a single dose of doxycycline. It does reduce the risk for some specific infections – but as always you need to know the numbers. We give you all of them and much, much more. To claim your CPD credits, click the link below and then select "Claim Credits Now." BS Medicine Episode #613: Doxycycline for post-exposure prophylaxis of sexually transmitted infections - CFPCLearn

In episode 611, Tina and James talk with Samantha Moe about the use of betablockers and other medications for essential tremor. There is some evidence – much of it from the 1970s, but also some more recent publications. We do our best to tease out all the numbers you need to help you with your recommendations. Show Notes Tools For Practice Meds for Essential Tremor: Steady solution or shaky science?

No description provided.

Un nouvel épisode du Pharmascope est maintenant disponible! Dans de ce 115ème épisode, Sébastien, Nicolas et Isabelle terminent leur série d'épisodes sur l'ostéoporose. Dans cette troisième et dernière partie, on aborde la prise en charge suite à une fracture, les marqueurs du remodelage osseux, l'ostéoporose induite par les corticostéroïdes et la prise concomitante de suppléments de calcium et de vitamine D lors de l'utilisation d'un traitement pharmacologique. Les objectifs pour cet épisode sont les suivants: Discuter de la prise en charge des patients qui ont subi une fracture de fragilisation Discuter de l'utilité des marqueurs biochimiques du remodelage osseux Résumer la prise en charge de l'ostéoporose induite par les corticostéroïdes Conseiller adéquatement la prise d'un supplément de calcium et de vitamine D aux patients prenant un traitement pharmacologique contre l'ostéoporose Ressources pertinentes en lien avec l'épisode Qaseem A et coll; Clinical Guidelines Committee of the American College of Physicians. Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians. Ann Intern Med. 2023;176:224-38. National Osteoporosis Guideline Group – UK. Clinical Guideline for the Prevention and Treatment of Osteoporosis 2021. Septembre 2021. Moe S, Paige A, Allan GM. Osteoporosis in postmenopausal women. Can Fam Physician. 2021;67:346. Nayak S, Greenspan SL. Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta-Analysis. J Am Geriatr Soc. 2017;65:490-95. National Institute for Health and Care Excellence (NICE). Osteoporosis: assessing the risk of fragility fracture. London; 2017. Papaioannou A et coll. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010;182:1864-73. Management of Osteoporosis in Postmenopausal Women: The 2021 Position Statement of The North American Menopause Society'' Editorial Panel. Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society. Menopause. 2021;28:973-97. Bessette L et coll. The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int. 2008;19:79-86. Deng J et coll. Pharmacological prevention of fractures in patients undergoing glucocorticoid therapies: a systematic review and network meta-analysis. Rheumatology. 2021;60:649-57. Calculateur FRAX Centre for Metabolic Bone Diseases. FRAX: Fracture Risk Assessment Tool. University of Sheffield, UK. Outil d'aide à la décision Mayo Foundation for Medical Education and Research. Bone Health Choice Decision Aid. Mayo Clinic, USA.

Un nouvel épisode du Pharmascope est maintenant disponible! Dans de ce 113ème épisode, Sébastien, Nicolas et Isabelle débutent une série d'épisodes sur l'ostéoporose. Dans ce premier épisode, on aborde le dépistage, l'évaluation et le diagnostic de l'ostéoporose, une maladie qui n'en est peut-être pas vraiment une… Les objectifs pour cet épisode sont les suivants: Définir l'ostéoporose Identifier les patients nécessitant un dépistage de l'ostéoporose Expliquer les avantages et les limites d'une ostéodensitométrie Évaluer le risque de fracture d'un patient Ressources pertinentes en lien avec l'épisode National Institute for Health and Care Excellence (NICE). Osteoporosis: assessing the risk of fragility fracture. London; 2017. US Preventive Services Task Force. Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319:2521-31. Viswanathan M et coll. Screening to Prevent Osteoporotic Fractures: An Evidence Review for the U.S. Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018. (Evidence Synthesis, No. 162. Papaioannou A et coll. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010;182:1864-73. Korownyk C, McCormack J, Allan GM. Who should receive bone mineral density testing? Can Fam Physician. 2015;61:612. Choisir avec soin. L'ostéodensitométrie. Canada. Management of Osteoporosis in Postmenopausal Women: The 2021 Position Statement of The North American Menopause Society'' Editorial Panel. Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society. Menopause. 2021;28:973-97. Calculateur FRAX Centre for Metabolic Bone Diseases. FRAX: Fracture Risk Assessment Tool. University of Sheffield, UK.